Impact of Valganciclovir Prophylaxis Duration on Cytomegalovirus Disease in High-Risk Donor Seropositive/Recipient Seronegative Heart Transplant Recipients

BACKGROUND: Few data support current guideline recommendations for 6 months over 3 months of antiviral prophylaxis for cytomegalovirus (CMV) disease prevention in donor seropositive/recipient seronegative (D+R-) heart transplant recipients (HTR). METHODS: We retrospectively assessed CMV disease and...

Full description

Saved in:
Bibliographic Details
Published in:Transpl Infect Dis
Main Authors: Imlay, Hannah, Carcoana, Allison O. Dumitriu, Fisher, Cynthia E., Wong, Beatrice, Rakita, Robert M., Fishbein, Daniel P., Limaye, Ajit P.
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284827/
https://ncbi.nlm.nih.gov/pubmed/32020736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.13255
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items